Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 6/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 5/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL406836 | 1.00 | RELA (0.47) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| Benzene SCHEMBL28121379 | 1.00 | RELA (0.47) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL6055045 | 1.00 | RELA (0.47) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL15552968 | 0.94 | LTA4H (0.44) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL924663 | 0.94 | LTA4H (0.44) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL23244048 | 0.93 | EGFR (0.45) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL6313346 | 0.93 | EGFR (0.45) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL21596608 | 0.93 | EGFR (0.45) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL7540402 | 0.93 | EGFR (0.45) | RELATDP1LTA4HCHRNA7CHRNA10 | |
| SCHEMBL7541675 | 0.93 | EGFR (0.45) | RELATDP1LTA4HCHRNA7CHRNA10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796647-B2 | Method for producing fluorine-containing olefin | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20170101360-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-04-13 | — | — | US | disclosed |
| US-9598335-B2 | Method for producing fluorine-containing olefin | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-03-21 | — | — | US | disclosed |
| EP-3042889-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | Asahi Glass Company, Limited (JP) | 2016-07-13 | — | — | EP | disclosed |
| US-20160176791-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101360-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | FOS, CYP2F1, CYP4F11 | RELA 3648/4885TDP1 3504/4885LTA4H 3734/4885 |
| US-20160176791-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | FOS, CYP2F1, CYP4F11 | RELA 3648/4885TDP1 3504/4885LTA4H 3734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.